Valeant Pharmaceuticals Acquires Visudyne From QLT

Valeant Pharmaceuticals announced it has acquired Visudyne, used to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration, from QLT.
The Sacramento Bee